Intermittent Parathyroid Hormone Administration Stimulates Bone Formation in the Mandibles of Aged Ovariectomized Rats

Abstract

Intermittent administration of parathyroid hormone (PTH) is known to stimulate bone formation in many skeletal sites and is being investigated as a possible therapeutic agent for the treatment of osteopenic conditions, including post-menopausal osteoporosis. The purpose of this study was to determine the ability of PTH to stimulate bone formation in the mandibles of aged ovariectomized (Ovx) rats, and the results are compared with a site in the appendicular skeleton (humerus). The Ovx rat is a useful model of estrogen deficiency, replicating many aspects of post-menopausal osteoporosis. Female rats were ovariectomized or sham-operated, and one year later a group of the ovariectomized rats was treated with the 1-34 fragment of human PTH daily, five days a week for 10 weeks. During the experiment, the animals were given fluorochrome bone markers for histomorphometry. More than one year after ovariectomy or sham surgery, there were few differences in the histomorphometric indices of bone formation in the humerus or mandible. PTH treatment had no effect on dentin formation, measured in the mandibular incisor; however, most indices of bone formation-including the double-labeled surface, mineralizing surface, mineral appositional rate, new bone area, and surface-referent bone formation rates-were substantially greater in the PTH-treated group compared with both the Ovx and the Sham controls measured at the periosteal and endocortical surfaces of the humerus and the periosteal and cancellous bone surfaces of the mandible. In addition, bone formation at the alveolar crest, particularly on the buccal side, was greater in the PTH-treated group. The results from this study demonstrate that systemic intermittent PTH treatment stimulates bone formation in the mandibles in aged, estrogen-deficient animals.

Keywords

parathyroid hormone bone formation mandible estrogen deficiency ovariectomy rats.

Get full access to this article

View all access options for this article.

References

Bagi CM , Miller SC , Bowman BM , Blomstrom GL , France EP (1992). Differences in cortical bone in overloaded and underloaded femurs from ovariectomized rats: comparison of bone morphometry with torsional testing. Bone 13:35-40.

Baumann BD , Wronski TJ (1995). Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247-253.

Dempster DW , Cosman F. , Parisien M. , Shen V. , Lindsay R. (1993). Anabolic actions of parathyroid hormone on bone . Endocrine Rev 14:690-709.

Ejersted C. , Andreassen TT , Hauge E. -M, Melsen F. , Oxlund H. (1995). Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 17:507-511.

Elovic RP , Hipp JA , Hayes WC (1995). Ovariectomy decreases the bone area fraction of the rat mandible. Calcif Tissue Int 56:305-310.

Gunness-Hey M. , Hock JM ( 1984). Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5:177-181.

Jeffcoat MK , Chesnut CH 3d (1993). Systemic osteoporosis and oral bone loss: evidence shows increased risk factors. J Am Dent Assoc 124:49-56.

Klemetti E. , Vainio P. , Lassila V. , Alhava E. (1993). Trabecular bone mineral density of mandible and alveolar height in postmenopausal women. Scand J Dent Res 101:166-170.

Li M. , Mosekilde L. , Sogaard CH , Thomsen JS , Wronski TJ (1995). Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone 16:629-635.

10.

Liu CC , Kalu DN ( 1990). Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Min Res 5:973-982.

11.

Miller SC , Omura TH , Smith LJ (1985). Changes in dentin appositional rates during pregnancy and lactation in rats. J Dent Res 64:1062-1064.

12.

Miller SC , Bowman BM , Miller MA , Bagi CM ( 1991). Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats. Bone 12:439-446.

13.

Mohajery M. , Brooks SL (1992). Oral radiographs in the detection of early signs of osteoporosis. Oral Surg Oral Med Oral Pathol 73:112-117.

14.

Nishimura I. , Hosokawa R. , Atwood DA (1992). The knife-edge tendency in mandibular residual ridges in women. J Prosthet Dent 67:820-826.

15.

Norderyd OM , Grossi SG , Machtei EE , Zambon JJ , Hausmann E. , Dunford RG , et al. (1993). Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontal 64:957-962.

16.

Parfitt AM , Drezner MK , Glorieux FH , Kanis JA , Malluche H. , Meunier PJ , et al. (1987). Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Min Res 2:595-610.

17.

Qi H. , Li M. , Wronski TJ (1995). A comparison of the anabolic Shen V. , Dempster DW , Mellish RW , Birchman R. , Horbert W. , Lindsay R. (1992). Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia . Calcif Tissue Int 50:214-220.

18.

Selye H. (1932). On the stimulation of new bone-formation with parathyroid extract, irradiated ergosterol. Endocrinology 16:547-558.

19.

von Wowem N. , Klausen B. , Kollerup G. (1994). Osteoporosis: a risk factor in periodontal disease . J Periodontol 65:1134-1138. Wronski TJ , Yen CF (1994). Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:51-58.

20.

Wronski TJ , Yen CF , Qi H. , Dann LM ( 1993). Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831.